4.3 Review

Bone marrow cell therapy and cardiac reparability: better cell characterization will enhance clinical success

期刊

REGENERATIVE MEDICINE
卷 13, 期 4, 页码 457-475

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/rme-2017-0134

关键词

aging; heart; ischemia; myocardium; regeneration; stem cells

向作者/读者索取更多资源

Nearly two decades of experimental and clinical research with bone marrow cells have paved the way for Phase III pivotal trials in larger groups of heart patients. Despite immense advancements, a multitude of factors are hampering the acceptance of bone marrow cell-based therapy for routine clinical use. These include uncertainties regarding purification and characterization of the cell preparation, delivery protocols, mechanistic understanding and study end points and their methods of assessment. Clinical data show mediocre outcomes in terms of sustained cardiac pump function. This review reasons that the modest outcomes observed in trials thus far are based on quality of the cell preparation with a focus on the chronological aging of cells when autologous cells are used for transplantation in elderly patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据